Patient P-03061
Therapy response
Declining
Tolerance
Improving
GI state
Favorable
Inflammatory state
Improving
Nutritional resilience
Favorable
Discontinuation risk
21%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 ONX-7 started — Baseline state S20
- Day 94 GI-04 recommended — GI Support Protocol GI-04
- Day 95 Patient accepted — Started GI-04 in the companion
- Day 103 No meaningful change — GI Support Protocol GI-04
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity-9
- Toxicity-9
- GI instability+4
- Treatment adherence+3
- Nutritional resilience+2
What helped?
- GI Support Protocol GI-04Day 94Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Energy level
Daily log5.6/10
stable · -0.2 vs previous 14 d
Stress level
Daily log3.2/10
stable · +0.1 vs previous 14 d
Pessimism score
Daily log2.9/10
worsening · +0.4 vs previous 14 d
Sleep quality
Wearable57.3/100
worsening · -3.9 vs previous 14 d
Libido
Daily log5.4/10
stable · +0.1 vs previous 14 d
HRV
Wearable61.8 ms
stable · +0.5 vs previous 14 d
Toxicity
Blood14.9/100
improving · -4.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 70 from the failing basin, 20 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.3 next day on high-intake days · n 19
Would not help
- GI-04 GI Support Protocolalready tried, no meaningful change
- AD-05 Adherence Supportonly 44% improved among 9 similar
- Keep lactose lowGI +3.7 next day on high-intake days · n 18
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.3supporter · 95%
- Lactose+3.7detractor · 95%
- Histamine load+1.8no signal · 31%
- Caffeine+1.3no signal · 24%
- Alcohol+0.4no signal · 15%
- Dietary fat load-0.3no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓25
- WearableResting HR 74 bpm
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 4.1 · butyrate capacity 72/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumLow
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 62 ms
- Sleep
- 7.3 h
- Steps
- 8,864
- Resting HR
- 75 bpm
Daily log: GI score 26, nutritional resilience 66, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-03252 | 47% | S13 | SC-12 | improved | 68 |
| P-03208 | 46% | S02 | BR-03 | improved | 57 |
| P-03178 | 45% | S11 | GI-04 | improved | 54 |
| P-03473 | 45% | S07 | DT-01 | improved | 70 |
| P-03193 | 41% | S13 | DT-01 | improved | 53 |
| P-03374 | 41% | S19 | ME-01 | improved | 55 |
| P-03408 | 40% | S09 | HY-01 | improved | 53 |
| P-03057 | 39% | S14 | NP-02 | improved | 64 |
| P-03213 | 39% | S02 | DT-01 | improved | 59 |
| P-03442 | 39% | S11 | DT-01 | improved | 51 |
| P-03268 | 38% | S15 | DT-01 | improved | 56 |
| P-03449 | 38% | S14 | DT-01 | improved | 79 |